Blu – Pagina 96 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Ottobre 7, 2024 Alice Lione

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies

Nabrdalik K, Hendel M, Irlik K, et al.
BMC Endocr Disord. Pub. online 30 Sep 2024.

Leggi

Ottobre 7, 2024 Alice Lione

Associations between weight self-stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross-sectional results from the second Diabetes MILES – Australia (MILES-2) study

Manallack S, Holloway EE, Pouwer F, et al.
Diabet Med. Pub. online 30 Sep 2024.

Leggi

Ottobre 3, 2024 Alice Lione

An evaluation of how exercise position statement guidelines are being used in the real world in type 1 diabetes: Findings from the type 1 diabetes exercise initiative (T1DEXI)

Jacobs PG, Chase Marak M, Calhoun P, et al.
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.

Leggi

Ottobre 3, 2024 Alice Lione

Estimated long-term benefits of finerenone in heart failure: a prespecified secondary analysis of the FINEARTS-HF randomized clinical trial

Vaduganathan M, Claggett BL, Desai AS, et al.
JAMA Cardiol. Pub. online 27 Sept 2024.

Leggi

Ottobre 3, 2024 Alice Lione

Effects of the non-steroidal MRA finerenone with and without concomitant SGLT2 inhibitor use in heart failure

Vaduganathan M, Claggett BL, Kulac IJ, et al.
Circulation. Pub. online 28 Sept 2024.

Leggi

Ottobre 3, 2024 Alice Lione

Ambulatory blood pressure monitoring and vascular complications in patients with type 1 diabetes mellitus – Systematic review and meta-analysis of observational studies

Costa Hoffmeister M, Hammel Lovison V, Priesnitz Friedrich E, da Costa Rodrigues T
Diabetes Res Clin Pract. Pub. online 27 Sept 2024.

Leggi

Ottobre 3, 2024 Alice Lione

Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

Kosiborod MN, Windsor SL, Vardeny O, et al.
Lancet Diabetes Endocrinol. 2024;12(10):725-734.

Leggi

Ottobre 3, 2024 Alice Lione

Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials

Karakasis P, Koufakis T, Patoulias D, et al.
Diabetes Obes Metab. Pub. online 30 Sept 2024.

Leggi

Ottobre 3, 2024 Alice Lione

Ertugliflozin to reduce arrhythmic burden in patients with ICDs/CRT-Ds

Benedikt M, Oulhaj A, Rohrer U, et al.
NEJM Evid. 2024;3(10):EVIDoa2400147.

Leggi

Ottobre 3, 2024 Alice Lione

Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

Yachida J, Fujihara K, Harada Yamada M, et al.
Diabetes Obes Metab. Pub. online 24 Sept 2024.

Leggi